CN104758920A - Gout health care product based on homology of medicine and food - Google Patents
Gout health care product based on homology of medicine and food Download PDFInfo
- Publication number
- CN104758920A CN104758920A CN201510209338.2A CN201510209338A CN104758920A CN 104758920 A CN104758920 A CN 104758920A CN 201510209338 A CN201510209338 A CN 201510209338A CN 104758920 A CN104758920 A CN 104758920A
- Authority
- CN
- China
- Prior art keywords
- health care
- care product
- gout
- edible
- integration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a gout health care product based on the homology of medicine and food. According to the technical scheme, the gout health care product includes ocean fish oligopeptide powder, poria cocos and lophatherum gracile, and preferably, the weight ratio of the ocean fish oligopeptide powder to the poria cocos to the lophatherum gracile is 1 to 0.5-1.5 to 0.5-1.5. The gout health care product based on the homology of medicine and food is scientific in compatibility of medicines, synergistic interaction is achieved, high uric acid can be effectively restrained, uratoma can be removed, immunity is enhanced, the effects of adjusting the immunity and lowering the uric acid are achieved, and no side effect is achieved.
Description
Technical field
The invention belongs to field of health care products, relate to a kind of gout health care product based on integration of edible and medicinal herbs particularly.
Background technology
Gout refers to that in human body, the metabolism of purine substance gets muddled, the synthesis of uric acid increases or discharges and reduces, and causes hyperuricemia, when serum Uric Acid Concentration is too high, uric acid is deposited in joint, cartilage and kidney with the form of sodium salt, causes and organizes foreign body inflammatory reaction.Gout is distributed in all over the world, by race, diet, drink, the multifactor impact such as professional, environment and schooling.The prevalence of European and American areas gout is 0.2% ~ 1.7%.In China, the sickness rate of gout is also in rising trend in recent years.Gout is first of hundred pains, once the thorough heart of outbreak pain, hotch, diseased joints is cannot moved, and therefore, gout has a strong impact on daily life and work.After suffering from gout, as not in time for, the lighter causes joint to have an intense pain, and kidney damage and hypertension can appear in serious words, angina pectoris, a series of disease such as diabetes.The existing medicine for gout is mainly Western medicine, and Western medicine is mainly chemosynthesis material, has certain toxic and side effects.
Summary of the invention
In order to overcome the above problems, the invention provides a kind of to gout Be very effective, based on the gout health care product of integration of edible and medicinal herbs.
The technical solution used in the present invention is: a kind of gout health care product based on integration of edible and medicinal herbs, containing the oligomeric Gly-His-Lys of marine fish, Poria and Herba Lophatheri.Preferably, the weight ratio of the oligomeric Gly-His-Lys of marine fish, Poria and Herba Lophatheri is 1:0.5-1.5:0.5-1.5.
Above-mentioned a kind of gout health care product based on integration of edible and medicinal herbs, also containing Stigma Maydis.Preferably, the weight ratio of the oligomeric Gly-His-Lys of marine fish, Poria, Herba Lophatheri and Stigma Maydis is 1:0.5-1.5:0.5-1.5:0.1-1.0.
Above-mentioned a kind of gout health care product based on integration of edible and medicinal herbs, in order to prepare the various peroral dosage form being convenient to take or the taste in order to meet different crowd, also containing medically acceptable pharmaceutic adjuvant.Pharmaceutic adjuvant comprises excipient, stabilizing agent or in order to sweeting agent meeting different taste etc.
Preferably, above-mentioned a kind of gout health care product based on integration of edible and medicinal herbs, composed as follows by weight percentage: the oligomeric Gly-His-Lys 5-7% of marine fish, Poria 4-7%, Herba Lophatheri 5-8%, pharmaceutic adjuvant surplus.Preferred, the oligomeric Gly-His-Lys 6-6.5% of marine fish, Poria 5-6%, Herba Lophatheri 6.5-7.5%, pharmaceutic adjuvant surplus.
Preferably, above-mentioned a kind of gout health care product based on integration of edible and medicinal herbs, composed as follows by weight percentage: the oligomeric Gly-His-Lys 5-7% of marine fish, Poria 4-7%, Herba Lophatheri 5-8%, Stigma Maydis 2-5%, pharmaceutic adjuvant surplus.Preferred, the oligomeric Gly-His-Lys 6-6.5% of marine fish, Poria 5-6%, Herba Lophatheri 6.5-7.5%, Stigma Maydis 3-4%, pharmaceutic adjuvant surplus.
For the ease of oral, health product are made tablet, electuary, capsule or pill.
The invention has the beneficial effects as follows: the present invention with the oligomeric Gly-His-Lys of marine fish, Poria and Herba Lophatheri for raw material, make the health product of integration of edible and medicinal herbs, scientific compatibility, mutual synergism, effectively can suppress metabolic arthritis, removes tophus, enhancing immunity, there is immunity moderation power, the effect of uric acid resisting, and have no side effect.
Detailed description of the invention
Embodiment 1 one kinds is based on the gout health care product of integration of edible and medicinal herbs
(1) formula
The oligomeric Gly-His-Lys of marine fish, Poria and Herba Lophatheri, get the raw materials ready by weight 1:1:1.
(2) by above-mentioned raw material, grinding, mix homogeneously, makes electuary.
(3) effect
1, physical data
Patient 180 example, wherein male 88 example, women 92 example.
2, diagnostic criteria:
Arthralgia, patient at night shows effect, and pain, is difficult to fall asleep;
Hyperuricemia: blood uric acid increases, male more than 0.38-mmol/L; More than women 0.3lnenol/L.
Tophus: there is tophus
3, instructions of taking
Get 5g, with mixing in water for oral taking, every day takes 2 times sooner or later at every turn, takes 2-3 month continuously.
4, efficacy assessment standard
Cure: symptoms of joint pain disappears, lab testing Level of Serum Uric Acid is normal, and tophus is removed.
Take a turn for the better: arthroncus is disappeared, pain relief, and lab testing Level of Serum Uric Acid makes moderate progress, and tophus obviously reduces.
Invalid: symptom and lab testing Level of Serum Uric Acid unchanged, tophus is unchanged.
5, the results are shown in Table 1
Table 1
| Number of cases | Cure | Take a turn for the better | Invalid |
| After 2 months | 94 examples | 68 examples | 18 examples |
| After 3 months | 111 examples | 62 examples | 7 examples |
From table 1, after 3 months, total effective rate reaches 96.1%.
Embodiment 2 one kinds is based on the gout health care product of integration of edible and medicinal herbs
Composed as follows by weight percentage: the oligomeric Gly-His-Lys 6-6.5% of marine fish, Poria 5-6%, Herba Lophatheri 6.5-7.5%, pharmaceutic adjuvant surplus, pharmaceutic adjuvant comprises orange taste agent.After getting the raw materials ready, technique makes the tablet with orange taste routinely.
Every sheet 10g, every day 2 each a slices.Take and can obvious pain disappear the rear same day, Level of Serum Uric Acid is normal, and after 3 months, tophus is removed gradually, and total effective rate reaches 95.8%.
Embodiment 3 one kinds is based on the gout health care product of integration of edible and medicinal herbs
Composed as follows by weight percentage: the oligomeric Gly-His-Lys 6-6.5% of marine fish, Poria 5-6%, Herba Lophatheri 6.5-7.5%, Stigma Maydis 3-4%, pharmaceutic adjuvant surplus, pharmaceutic adjuvant comprises fruit flavor agent.
By above-mentioned raw material, grinding, mix homogeneously, makes electuary.According to different crowd's tastes, orange taste can be made, strawberry flavor, apple aroma etc.
Each 10g, every day 2 times.Have mitigation to the pain of gout, long-term taking, tophus is removed gradually.
Claims (9)
1. based on gout health care product for integration of edible and medicinal herbs, it is characterized in that: containing the oligomeric Gly-His-Lys of marine fish, Poria and Herba Lophatheri.
2. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 1, is characterized in that: the weight ratio of the oligomeric Gly-His-Lys of marine fish, Poria and Herba Lophatheri is 1:0.5-1.5:0.5-1.5.
3. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 1, is characterized in that: containing Stigma Maydis, and the weight ratio of the oligomeric Gly-His-Lys of marine fish, Poria, Herba Lophatheri and Stigma Maydis is 1:0.5-1.5:0.5-1.5:0.1-1.0.
4. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 1,2 or 3, is characterized in that: containing medically acceptable pharmaceutic adjuvant.
5. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 4, is characterized in that: composed as follows by weight percentage: the oligomeric Gly-His-Lys 5-7% of marine fish, Poria 4-7%, Herba Lophatheri 5-8%, pharmaceutic adjuvant surplus.
6. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 5, is characterized in that: composed as follows by weight percentage: the oligomeric Gly-His-Lys 6-6.5% of marine fish, Poria 5-6%, Herba Lophatheri 6.5-7.5%, pharmaceutic adjuvant surplus.
7. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 4, is characterized in that: composed as follows by weight percentage: the oligomeric Gly-His-Lys 5-7% of marine fish, Poria 4-7%, Herba Lophatheri 5-8%, Stigma Maydis 2-5%, pharmaceutic adjuvant surplus.
8. a kind of gout health care product based on integration of edible and medicinal herbs according to claim 7, is characterized in that: composed as follows by weight percentage: the oligomeric Gly-His-Lys 6-6.5% of marine fish, Poria 5-6%, Herba Lophatheri 6.5-7.5%, Stigma Maydis 3-4%, pharmaceutic adjuvant surplus.
9. according to claim 1,2,3,5,6,7 or 8, any, based on the gout health care product of integration of edible and medicinal herbs, is characterized in that: it is characterized in that: health product are made tablet, electuary, capsule or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510209338.2A CN104758920A (en) | 2015-04-29 | 2015-04-29 | Gout health care product based on homology of medicine and food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510209338.2A CN104758920A (en) | 2015-04-29 | 2015-04-29 | Gout health care product based on homology of medicine and food |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104758920A true CN104758920A (en) | 2015-07-08 |
Family
ID=53641235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510209338.2A Pending CN104758920A (en) | 2015-04-29 | 2015-04-29 | Gout health care product based on homology of medicine and food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104758920A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126067A (en) * | 2015-09-30 | 2015-12-09 | 北京知蜂堂蜂产品有限公司 | Composition for reducing uric acid and application thereof |
| CN105831219A (en) * | 2016-06-14 | 2016-08-10 | 王金国 | Food suitable for acid-base equilibrium of uric acid |
| CN105943958A (en) * | 2016-06-03 | 2016-09-21 | 黑龙江省玄鸟生物科技股份有限公司 | Inonotus obliquus composite solid particles for treating gout and preparing method thereof |
| CN106036915A (en) * | 2016-05-24 | 2016-10-26 | 张雅萍 | Special diet composition containing marine active polypeptide as well as preparation method and application of special diet composition |
| CN106805234A (en) * | 2016-12-19 | 2017-06-09 | 江苏红瑞制药有限公司 | A kind of anti-trioxypurine food compositions |
| CN107660795A (en) * | 2017-09-01 | 2018-02-06 | 武汉龙族药号生物医药科技有限公司 | One kind prevention gout plaster taste and preparation method thereof |
| CN107951022A (en) * | 2017-12-28 | 2018-04-24 | 陆淼兴 | A kind of marine fish oligopeptide mixture and its preparation and preparation method |
| CN109122859A (en) * | 2018-11-01 | 2019-01-04 | 威海健康生生物科技有限公司 | Anti-trioxypurine composition and the preparation method and application thereof |
| CN109770141A (en) * | 2019-03-08 | 2019-05-21 | 唐凯 | A kind of drink eaten suitable for the high crowd of uric acid |
| CN109938349A (en) * | 2019-03-29 | 2019-06-28 | 宁波御坊堂生物科技有限公司 | A kind of oligomeric peptide functional food and preparation method thereof |
| CN114246933A (en) * | 2021-12-01 | 2022-03-29 | 广州宏韵医药科技股份有限公司 | Composition and food for reducing uric acid, and preparation method and application thereof |
| CN114947124A (en) * | 2022-04-22 | 2022-08-30 | 北京恒生药业有限公司 | Solid composition with gout relieving effect and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062314A (en) * | 2007-05-25 | 2007-10-31 | 长春中医药大学 | Medicine for curing gout and its preparing method |
| CN101732623A (en) * | 2009-12-08 | 2010-06-16 | 毕哲全 | Medicament for treating acute gouty arthritis and preparation method thereof |
| CN102754827A (en) * | 2012-06-24 | 2012-10-31 | 宁波市鄞州浩斯瑞普生物科技有限公司 | Food for hyperuricemia |
| CN104366636A (en) * | 2014-10-30 | 2015-02-25 | 袁丁 | Gynura procumbens compound preparation as well as preparation method and application thereof |
-
2015
- 2015-04-29 CN CN201510209338.2A patent/CN104758920A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062314A (en) * | 2007-05-25 | 2007-10-31 | 长春中医药大学 | Medicine for curing gout and its preparing method |
| CN101732623A (en) * | 2009-12-08 | 2010-06-16 | 毕哲全 | Medicament for treating acute gouty arthritis and preparation method thereof |
| CN102754827A (en) * | 2012-06-24 | 2012-10-31 | 宁波市鄞州浩斯瑞普生物科技有限公司 | Food for hyperuricemia |
| CN104366636A (en) * | 2014-10-30 | 2015-02-25 | 袁丁 | Gynura procumbens compound preparation as well as preparation method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 孙维峰等: "从痰瘀论治痛风及高尿酸血症体会", 《中国中西医结合杂志》 * |
| 袁学会等: "利用罗非鱼废弃碎肉制备低聚肽的研究", 《食品工业科技》 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126067B (en) * | 2015-09-30 | 2018-05-22 | 北京知蜂堂健康科技股份有限公司 | A kind of composition of anti-trioxypurine and application thereof |
| CN105126067A (en) * | 2015-09-30 | 2015-12-09 | 北京知蜂堂蜂产品有限公司 | Composition for reducing uric acid and application thereof |
| CN106036915A (en) * | 2016-05-24 | 2016-10-26 | 张雅萍 | Special diet composition containing marine active polypeptide as well as preparation method and application of special diet composition |
| CN105943958A (en) * | 2016-06-03 | 2016-09-21 | 黑龙江省玄鸟生物科技股份有限公司 | Inonotus obliquus composite solid particles for treating gout and preparing method thereof |
| CN105831219A (en) * | 2016-06-14 | 2016-08-10 | 王金国 | Food suitable for acid-base equilibrium of uric acid |
| CN106805234A (en) * | 2016-12-19 | 2017-06-09 | 江苏红瑞制药有限公司 | A kind of anti-trioxypurine food compositions |
| CN107660795A (en) * | 2017-09-01 | 2018-02-06 | 武汉龙族药号生物医药科技有限公司 | One kind prevention gout plaster taste and preparation method thereof |
| CN107951022A (en) * | 2017-12-28 | 2018-04-24 | 陆淼兴 | A kind of marine fish oligopeptide mixture and its preparation and preparation method |
| CN109122859A (en) * | 2018-11-01 | 2019-01-04 | 威海健康生生物科技有限公司 | Anti-trioxypurine composition and the preparation method and application thereof |
| CN109770141A (en) * | 2019-03-08 | 2019-05-21 | 唐凯 | A kind of drink eaten suitable for the high crowd of uric acid |
| CN109938349A (en) * | 2019-03-29 | 2019-06-28 | 宁波御坊堂生物科技有限公司 | A kind of oligomeric peptide functional food and preparation method thereof |
| CN114246933A (en) * | 2021-12-01 | 2022-03-29 | 广州宏韵医药科技股份有限公司 | Composition and food for reducing uric acid, and preparation method and application thereof |
| CN114947124A (en) * | 2022-04-22 | 2022-08-30 | 北京恒生药业有限公司 | Solid composition with gout relieving effect and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104758920A (en) | Gout health care product based on homology of medicine and food | |
| CN103238897B (en) | Composite plant solid drink suitable for diabetic patients | |
| US9603866B2 (en) | Anti-fatigue composition, formulation and use thereof | |
| EP3626249A2 (en) | Traditional chinese medicine healthcare preparation for fat elimination and weight reduction | |
| JP2020172523A (en) | Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system | |
| CN104306617B (en) | Composition containing maca and A Sayi fruits and its preparation method and application | |
| KR20120097516A (en) | Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages | |
| CN102920743A (en) | Application of spirulina in preparation of anti-hyperuricemia and anti-uarthritis medicine or health-care food | |
| JP2016532446A (en) | Enbu fermented food or beverage composition | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| CN105341893A (en) | Composition for assisting in reducing blood glucose and application | |
| WO2020039277A1 (en) | Enteral or oral nutritional composition | |
| CN108815218A (en) | Medical composition and its use | |
| CN105770870A (en) | Enzyme-contained natural composition and application thereof in pharmacy | |
| CN104770644A (en) | Diabetes health care product based on affinal drugs and diet | |
| CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
| GB2507254A (en) | Composition for reducing the consumption of food and the absorption of carbohydrate constituents thereof | |
| CN108450960A (en) | A kind of gout health care product based on integration of drinking and medicinal herbs | |
| GB2446373A (en) | Natural laxative composition for treating and preventing constipation with colon cleansing action | |
| CN205146094U (en) | Highland barley powder processing compounding instrument | |
| JP2014172902A (en) | Diabetic conditions improving agent of sargassum horneri fermentation product using lactobacillus plantarum | |
| CN105617069B (en) | Oral liquid for regulating bipolar affective disorder and preparation method thereof | |
| CN103948591B (en) | A kind of slimming agents | |
| JP3234642U (en) | Wheat flour composition for blood glucose and weight control containing Ascophyllum nodosum and / or extract of rockweed | |
| CN106511360A (en) | Composition containing ginsenoside Rg3 and silymarin and medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150708 |